148 related articles for article (PubMed ID: 6348763)
1. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Grassi C; Limido D; Pasquali S; Passerini P; Volpini T; Locatelli F
Proc Eur Dial Transplant Assoc; 1983; 19():717-23. PubMed ID: 6348763
[TBL] [Abstract][Full Text] [Related]
2. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T
N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B
N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605
[TBL] [Abstract][Full Text] [Related]
4. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
5. [Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results].
Imbasciati E; Cagnoli L; Case N; Pasquali S; Di Filippo G; Limido D; Cornalba L; Volpini T; Pozzi C; Zuccelli P; Ponticelli C
Minerva Nefrol; 1980; 27(4):571-5. PubMed ID: 7019771
[No Abstract] [Full Text] [Related]
6. Treatment of membranous lupus nephritis.
Moroni G; Maccario M; Banfi G; Quaglini S; Ponticelli C
Am J Kidney Dis; 1998 Apr; 31(4):681-6. PubMed ID: 9531186
[TBL] [Abstract][Full Text] [Related]
7. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of efficacy of methylprednisolone, prednisolone and chlorambucil in idiopathic glomerulonephritis.
Nand N; Das R; Jaswal TS
J Indian Med Assoc; 1997 Jun; 95(6):163-5, 174. PubMed ID: 9420390
[TBL] [Abstract][Full Text] [Related]
9. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
Polenakovik MH; Grcevska L
Am J Kidney Dis; 1999 Nov; 34(5):911-7. PubMed ID: 10561149
[TBL] [Abstract][Full Text] [Related]
10. Clinical and morphologic evolution of idiopathic membranous nephropathy.
Zucchelli P; Cagnoli L; Pasquali S; Casanova S; Donini U
Clin Nephrol; 1986 Jun; 25(6):282-8. PubMed ID: 3524923
[TBL] [Abstract][Full Text] [Related]
11. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
Polenakovic M; Grcevska L; Dzikova S
Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
Cattran DC; Delmore T; Roscoe J; Cole E; Cardella C; Charron R; Ritchie S
N Engl J Med; 1989 Jan; 320(4):210-5. PubMed ID: 2643046
[TBL] [Abstract][Full Text] [Related]
13. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
Grupe WE; Makker SP; Ingelfinger JR
N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
15. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood.
Williams SA; Makker SP; Ingelfinger JR; Grupe WE
N Engl J Med; 1980 Apr; 302(17):929-33. PubMed ID: 6987521
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
Lai KN; Lai FM; Ho CP; Chan KW
Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
[TBL] [Abstract][Full Text] [Related]
17. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
18. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
Reichert LJ; Huysmans FT; Assmann K; Koene RA; Wetzels JF
Ann Intern Med; 1994 Sep; 121(5):328-33. PubMed ID: 8042821
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic membranous nephropathy in the elderly.
Passerini P; Como G; Viganò E; Melis P; Pozzi C; Altieri P; Ponticelli C
Nephrol Dial Transplant; 1993; 8(12):1321-5. PubMed ID: 8159299
[TBL] [Abstract][Full Text] [Related]
20. The advantages of immunosuppressive therapy in renal disease.
Zucchelli P
Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]